Skip to main content
Clinical Case Reports logoLink to Clinical Case Reports
. 2020 Jul 16;8(11):2326–2327. doi: 10.1002/ccr3.3135

Continuous facial myokymia in multiple sclerosis

Jordan L Clay 1,, Mauricio F Villamar 2,3
PMCID: PMC7669365  PMID: 33235796

Abstract

Facial myokymia is a clinical sign that can occur as a manifestation of demyelinating lesions. As seen in our patient with multiple sclerosis, acute‐onset continuous facial myokymia can be indicative of an active lesion and can have localizing value.

Keywords: brainstem, facial myokymia, movement disorders, multiple sclerosis


Facial myokymia is a clinical sign that can occur as a manifestation of demyelinating lesions. As seen in our patient with multiple sclerosis, acute‐onset continuous facial myokymia can be indicative of an active lesion and of localizing value.

graphic file with name CCR3-8-2326-g002.jpg


A 54‐year‐old woman with relapsing‐remitting multiple sclerosis (MS) presented with 3 days of continuous facial “quivering” after self‐discontinuing dimethyl fumarate. Examination revealed continuous right perioral myokymia (Video S1). Figure 1 shows her neuroimaging. She received intravenous methylprednisolone. At 1‐month follow‐up, facial myokymia (FM) had resolved and dimethyl fumarate was restarted.

Figure 1.

Figure 1

Axial (Panel A) and sagittal (Panel B) postgadolinium T1‐weighted brain MRI revealed a new enhancing lesion in the right superior pons (arrows), ipsilateral to the patient's perioral myokymia

Facial myokymia is an involuntary, abnormal activity consisting of undulating, vermicular movements. 1 , 2 FM has been associated with lesions of the postnuclear, postgenu portion of the ipsilateral facial nerve intra‐axially in the dorsolateral pontine tegmentum. 1 However, many cases show no intra‐axial demyelination of the facial nerve. 2 In MS patients, FM is usually self‐limited. 2

CONFLICT OF INTEREST

None declared.

AUTHOR CONTRIBUTIONS

JLC: contributed to the case concept and design, acquired the data, interpreted the data, and wrote the manuscript. MFV: contributed to the case concept and design, acquired the data, interpreted the data, and wrote the manuscript.

Supporting information

Video S1

ACKNOWLEDGMENT

Published with written consent of the patient.

Clay JL, Villamar MF. Continuous facial myokymia in multiple sclerosis. Clin Case Rep. 2020;8:2326–2327. 10.1002/ccr3.3135

REFERENCES

  • 1. Jacobs L, Kaba S, Pullicino P. The lesion causing continuous facial myokymia in multiple sclerosis. Arch Neurol. 1994;51:1115‐1119. [DOI] [PubMed] [Google Scholar]
  • 2. Marín Collazo IV, Tobin WO. Facial myokymia and hemifacial spasm in multiple sclerosis: a descriptive study on clinical features and treatment outcomes. Neurologist. 2018;23(1):1‐6. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Video S1


Articles from Clinical Case Reports are provided here courtesy of Wiley

RESOURCES